- Home
- VOC vs MRSN Comparison
VOC vs MRSN Comparison
Compare VOC & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- MRSN
- Stock Information
- Founded
- VOC 2010
- MRSN 2001
- Country
- VOC United States
- MRSN United States
- Employees
- VOC N/A
- MRSN N/A
- Industry
- VOC Oil & Gas Production
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- VOC Energy
- MRSN Health Care
- Exchange
- VOC Nasdaq
- MRSN Nasdaq
- Market Cap
- VOC 51.3M
- MRSN 47.1M
- IPO Year
- VOC 2011
- MRSN 2017
- Fundamental
- Price
- VOC $2.87
- MRSN $8.34
- Analyst Decision
- VOC
- MRSN Strong Buy
- Analyst Count
- VOC 0
- MRSN 3
- Target Price
- VOC N/A
- MRSN $33.00
- AVG Volume (30 Days)
- VOC 103.6K
- MRSN 53.6K
- Earning Date
- VOC 01-01-0001
- MRSN 11-13-2025
- Dividend Yield
- VOC 21.66%
- MRSN N/A
- EPS Growth
- VOC N/A
- MRSN N/A
- EPS
- VOC 0.57
- MRSN N/A
- Revenue
- VOC $11,024,911.00
- MRSN $34,769,000.00
- Revenue This Year
- VOC N/A
- MRSN N/A
- Revenue Next Year
- VOC N/A
- MRSN N/A
- P/E Ratio
- VOC $4.96
- MRSN N/A
- Revenue Growth
- VOC N/A
- MRSN 16.14
- 52 Week Low
- VOC $2.44
- MRSN $5.21
- 52 Week High
- VOC $5.29
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- VOC 37.88
- MRSN 41.30
- Support Level
- VOC $2.81
- MRSN $8.00
- Resistance Level
- VOC $2.92
- MRSN $8.87
- Average True Range (ATR)
- VOC 0.09
- MRSN 0.67
- MACD
- VOC -0.04
- MRSN -0.32
- Stochastic Oscillator
- VOC 6.61
- MRSN 18.39
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.